Long-Term Outcomes of Antegrade Thoracic Stent Grafting During Repair of Acute DeBakey I Dissection.
Journal
The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R
Informations de publication
Date de publication:
23 Aug 2024
23 Aug 2024
Historique:
received:
09
02
2024
revised:
24
06
2024
accepted:
29
07
2024
medline:
26
8
2024
pubmed:
26
8
2024
entrez:
25
8
2024
Statut:
aheadofprint
Résumé
We aim to evaluate the impact of antegrade stenting of the distal arch and proximal descending aorta combined with non-total arch procedures in acute type A aortic dissection. From 2005 to 2022, 733 non-syndromic patients presented with acute DeBakey type I aortic dissection and underwent non total arch procedure. Ninety-five patients underwent antegrade stenting and 638 did not. Propensity-score analysis was performed, and 95 optimal pairs were created. Survival was estimated using the Kaplan-Meier method and cumulative incidence of reintervention with death as a competing event was calculated and compared using Gray's method. Survival estimates at 10 years after propensity score matching were similar between both group 58.9% (95%CI: 46.5-74.5) versus 58.4% (95%CI: 48.3-70.6) (p=0.6) in the non-stented versus stented group respectively. Cumulative incidence of reintervention with competing risk of death at 10 years after propensity matching was 27% (95%CI: 17-37) versus 22% (95%CI: 14-32) (p=0.44). Antegrade TEVAR may be beneficial for remodeling and facilitating future endovascular reinterventions and reduces the occurence of reintervention for malperfusion.
Sections du résumé
BACKGROUND
BACKGROUND
We aim to evaluate the impact of antegrade stenting of the distal arch and proximal descending aorta combined with non-total arch procedures in acute type A aortic dissection.
METHODS
METHODS
From 2005 to 2022, 733 non-syndromic patients presented with acute DeBakey type I aortic dissection and underwent non total arch procedure. Ninety-five patients underwent antegrade stenting and 638 did not. Propensity-score analysis was performed, and 95 optimal pairs were created. Survival was estimated using the Kaplan-Meier method and cumulative incidence of reintervention with death as a competing event was calculated and compared using Gray's method.
RESULTS
RESULTS
Survival estimates at 10 years after propensity score matching were similar between both group 58.9% (95%CI: 46.5-74.5) versus 58.4% (95%CI: 48.3-70.6) (p=0.6) in the non-stented versus stented group respectively. Cumulative incidence of reintervention with competing risk of death at 10 years after propensity matching was 27% (95%CI: 17-37) versus 22% (95%CI: 14-32) (p=0.44).
CONCLUSIONS
CONCLUSIONS
Antegrade TEVAR may be beneficial for remodeling and facilitating future endovascular reinterventions and reduces the occurence of reintervention for malperfusion.
Identifiants
pubmed: 39182554
pii: S0003-4975(24)00683-0
doi: 10.1016/j.athoracsur.2024.07.045
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024. Published by Elsevier Inc.